A genetic bottleneck explains the marked changes in mitochondrial DNA (mtDNA) heteroplasmy that are observed during the transmission of pathogenic mutations, but the precise timing of these changes remains controversial, and it is not clear whether selection has a role. These issues are important for the genetic counseling of prospective mothers and for the development of treatments aimed at disease prevention. By studying mice transmitting a heteroplasmic single-base-pair deletion in the mitochondrial tRNA Met gene, we show that the extent of mammalian mtDNA heteroplasmy is principally determined prenatally within the developing female germline. Although we saw no evidence of mtDNA selection prenatally, skewed heteroplasmy levels were observed in the offspring of the next generation, consistent with purifying selection. High percentages of mtDNA genomes with the tRNA Met mutation were linked to a compensatory increase in overall mitochondrial RNA levels, ameliorating the biochemical phenotype and explaining why fecundity is not compromised.
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A genetic bottleneck explains the marked changes in mitochondrial DNA (mtDNA) heteroplasmy that are observed during the transmission of pathogenic mutations, but the precise timing of these changes remains controversial, and it is not clear whether selection has a role. These issues are important for the genetic counseling of prospective mothers and for the development of treatments aimed at disease prevention. By studying mice transmitting a heteroplasmic single-base-pair deletion in the mitochondrial tRNA Met gene, we show that the extent of mammalian mtDNA heteroplasmy is principally determined prenatally within the developing female germline. Although we saw no evidence of mtDNA selection prenatally, skewed heteroplasmy levels were observed in the offspring of the next generation, consistent with purifying selection. High percentages of mtDNA genomes with the tRNA Met mutation were linked to a compensatory increase in overall mitochondrial RNA levels, ameliorating the biochemical phenotype and explaining why fecundity is not compromised.
First proposed 30 years ago, the mtDNA genetic bottleneck hypothesis provides an explanation for the rapid shifts in the extent of mtDNA heteroplasmy, the coexistence of different mtDNA genotypes within the same cell, that occur during the maternal transmission of pathogenic mutations 1, 2 . According to this hypothesis, only a limited number of identical segregating units populate the next generation, causing a statistical sampling effect and explaining why different siblings have markedly different heteroplasmy levels. Recently developed cell labeling and molecular genetic techniques have made it possible to test this hypothesis directly and to determine the underlying biological mechanism of the bottleneck. The initial report of relatively high amounts of mtDNA within the early female germline 3 was challenged by two independent groups reporting a reduction in the intracellular mtDNA content shortly after germ cell specification 4, 5 . In silico modeling implied that the observed number of randomly segregating single mtDNA molecules could account for the variation in heteroplasmy seen in the offspring of heteroplasmic mice 4 . This was not supported by limited observations in a heteroplasmic mouse lineage 5 , which instead pointed to a bottleneck potentially resulting from the replication of a subpopulation of mitochondrial genomes within the germline cells. However, concerns about the reliability of measuring heteroplasmy variance from small sampling sizes called into question the strength of these conclusions 6 , and the precise timing and mechanism of the mitochondrial genetic bottleneck remain uncertain 7 .
Initial studies of human pedigrees suggested that mothers were equally likely to pass on high or low mtDNA heteroplasmy to their offspring, even when the mtDNA encoded highly deleterious pathogenic mutations 8 . However, subsequent population-based studies in carefully ascertained human pedigrees 9 implied that there was selection against deleterious alleles, raising the possibility that this selection was occurring during female germline development. It is notoriously difficult to exclude the possibility of ascertainment bias when studying human pedigrees transmitting mtDNA heteroplasmy 8 , and the lack of animal models transmitting obviously pathogenic mtDNA mutations has severely limited progress. To address these issues, we generated mice with putatively pathogenic mtDNA mutations, with the aim of studying mutations whose segregation more closely resembles that of mutations in families segregating mtDNA disease.
By backcrossing female mice carrying a mutant mtDNA polymerase (D257A PolgA exo − or mtDNA-mutator mice) 10 to wild-type males, we generated maternal lines transmitting a range of different mtDNA mutations 11 . We observed that mutations in protein-coding genes were subject to a filter of purifying selection and were preferentially eliminated within a few generations 11 . Yet, mutations in mitochondrial tRNA genes evaded selection, despite the fact that many of these mutations are potentially pathogenic in mice, consistent with tRNA mutations being the most common pathogenic substitutions in humans with mtDNA disease 12 .
Sequencing of the entire mitochondrial genome (Supplementary Table 1 ) of one mouse lineage revealed two previously unknown l e t t e r s mutations: m.5245T>C in the tRNA Cys gene and m.3875delC in the tRNA Met gene (Supplementary Fig. 1 ). Initially heteroplasmic, the m.5245T>C mutation rapidly segregated to homoplasmy in all organs tested (Supplementary Table 2), with no obvious adverse effect on the organism. The equivalent mutation has been described in humans with mitochondrial encephalopathy (m.5814T>C) 13, 14 . In contrast, the m.3875delC mutation remained heteroplasmic, and there was no change in the heteroplasmy levels from birth to adulthood in a variety of tissues relative to the levels detected in ear or tail clips (Supplementary Table 3 ). The percentage of mitochondrial genomes with the m.3875delC tRNA Met mutation did not vary significantly between different tissues and organs ( Fig. 1) , indicating that the mutation load measured in tail and ear samples was representative of the whole organism and that no tissue-specific selection occurred. However, we were unable to generate mice in which >86% of the mitochondrial genomes harbored the mutation through selective breeding (Fig. 2a) , implicating a selective effect specifically during transmission.
We therefore studied the distribution of heteroplasmy levels in 533 offspring born to 44 mothers transmitting the m.3875delC mutation (raw data are given in Supplementary Table 4) . Given the known dependence of offspring heteroplasmy on the extent of maternal heteroplasmy, we measured the heteroplasmy distribution in groups of offspring from mothers known to have similar percentages of mtDNA that harbored the mutation. The offspring mutation levels were binned into three groups on the basis of the mothers' heteroplasmy level, including those that had mothers with 40-60%, 61-70% and >70% of mitochondrial genomes with the m.3875delC mutation. A Kimura distribution most accurately describes mtDNA heteroplasmy and is in keeping with random genetic drift and no selection 15 . For each of the three groups, the distribution of heteroplasmy in the offspring was compared to a Kimura distribution. The groups that had mothers with 40-60% and >70% of mtDNA with the mutation both deviated significantly from the Kimura distribution (P = 0.04 and 0.03, respectively, Kolmogorov-Smirnov test), indicating that a mechanism other than random drift is affecting the segregation of this mutation. However, there was no difference in the frequency of surviving offspring born to mothers with <70% of mitochondrial genomes with the m.3875delC mutation (13 mothers, 192 pups born, 154 surviving) and mothers with >70% of mitochondrial genomes with the mutation (11 mothers, 155 pups born, 136 surviving) (P = 0.11), in spite of a skewed heteroplasmy distribution among offspring born to mothers with high heteroplasmy. This result suggests that fecundity was not compromised and that the mothers were not preferentially eating mildly sick pups harboring high heteroplasmy. The significant difference of the mutation level distribution in offspring from the expected distribution predicted from random drift theory and the obvious lack of offspring with high percentages of mtDNA harboring the mutation (Fig. 2a,b) imply that purifying selection against the m.3875delC tRNA Met mutation occurs before the formation of the offspring.
To determine when the selection was occurring, we analyzed cells of the developing female germline by crossing mice transmitting the heteroplasmic mtDNA m.3875delC mutation with a germline reporter line (Stella-GFP) 16 . We measured the extent of heteroplasmy in 819 primary germ cells (PGCs) from 18 embryos at 13.5 days postconception (d.p.c.). We observed a wide variation in heteroplasmy levels ( Fig. 2c) , with up to 100% of mitochondrial genomes harboring the mutation, in stark contrast to the distribution in the offspring where no offspring with a high mutation level were observed (Fig. 2a) . The distribution of mutation levels in the PGCs was consistent with a Kimura distribution (KolmogorovSmirnov test P = 0.5 for mothers with 40-60% mutant mtDNA, 0.5 for mothers with 61-70% mutant mtDNA and 0.2 for mothers with >70% mutant mtDNA) and is therefore consistent with random drift determining the extent of oocyte m.3875delC heteroplasmy before birth. The variance in heteroplasmy in 13.5 d.p.c. germ cells was similar to that found in offspring (Fig. 2d) . Thus, the variance in heteroplasmy among offspring is determined embryonically, consistent with a prenatal germline genetic bottleneck governing the segregation of mutated mtDNA.
The lack of selection in the germline at 13.5 d.p.c. prompted us to investigate the proportion of mutant mitochondrial genomes in (Fig. 2e) . In all five sets of oocytes, the mutation level distributions were consistent with the neutral drift theory (P = 0.31, 0.42, 0.51, 0.08 and 0.84 by Kolmogorov-Smirnov test). As a final test for neutral drift, we calculated the difference between the percentage of mtDNA with the mutation in the mothers and the corresponding percentages in the PGCs, oocytes and offspring (Fig. 3) . If present, purifying selection would appear in these plots as a significant negative correlation between the mother's mutation level and the mutation level in the next generation. Consistent with the Kimura distribution tests, the mutation levels in both PGCs and oocytes showed no significant correlation with that in the mothers, whereas the offspring showed a very strong and significant (P = 0.002, R = -0.93, linear fit) negative correlation, meaning that the offspring from mothers with higher heteroplasmy had lower average heteroplasmy than their mothers. Thus, all the data and the different analytical approaches showed no evidence for purifying selection at the PGC and oocyte level but provide strong evidence for selection acting on the offspring. Thus, we conclude that selection is likely to have occurred after the oocyte stage. These findings contrast with the conventional view that selection against deleterious mtDNA mutations occurs by oocyte attrition 17 . However, the absence of oocytes at the high end of the range (with >80% mutant mitochondrial genomes) and the limited data set (n = 5) make it unwise to draw conclusions about the low variance in the oocytes, and we therefore cannot be absolutely certain that selection has not taken place before oocyte formation.
To determine the molecular mechanism underpinning selection, we performed serial cytochrome c oxidase (COX) and succinate dehydrogenase (SDH) histochemistry, respiration measurements and isolated respiratory chain complex activities in mouse liver and heart tissues homoplasmic for the m.5245T>C tRNA Cys mutation, all showing no defect (data not shown). However, given that the heteroplasmic m.3875delC mutation affects the highly conserved tRNA Met anticodon loop, we determined whether the deletion affected tRNA folding and/or wobble base pairing during translation. Separation of total RNA extracts by PAGE followed by RNA blot analysis showed that the mutant tRNA Met transcripts were stable but migrated aberrantly in the gel, consistent with a conformational change in the tRNA Met structure induced by the m.3875delC mutation (Fig. 4a,b) . In keeping with this observation, the m.3875delC mutation led to a severe aminoacylation defect in heart and skeletal muscle and, to a lesser extent, in liver ( Fig. 4c and Supplementary Fig. 2 ). Figure 3 The average shift in the mutation level between the next generation and the mothers for PGCs, oocytes and offspring. M, mothers; O, next generation. Mutation levels were determined on the basis of the data shown in Figure 2 . Only the offspring show a significant negative correlation, indicative of purifying selection occurring after oocyte heteroplasmy levels are determined. Error bars, s.e.m. , 61-70% of mtDNA (n = 4-7) and >71% of mtDNA (n = 6-11) with the m.3875delC mutation. Expression levels are normalized to those of nuclear-encoded 18S rRNA. Error bars, s.e.m. *P < 0.05; **P < 0.01; ***P < 0.001, calculated relative to C57BL/6N with two-tailed equal-variance Student's t test.
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(f) In organello transcription in isolated heart mitochondria from 25-week-old controls and mutant mice with >70% of mitochondrial genomes carrying the m.3875delC mutation.
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Analysis of steady-state levels of mitochondrial transcripts in heart revealed a pronounced reduction in tRNA Cys levels associated with the homoplasmic m.5245T>C mutation (Fig. 4d) , irrespective of the extent of m.3875delC heteroplasmy in the tRNA Met gene. However, increasing percentages of mitochondrial genomes with the m.3875delC mutation were accompanied by a progressive increase in steady-state levels of all other mitochondrial mRNAs and tRNAs apart from ND6 (Fig. 4e) , likely reflecting a compensatory response to both mtDNA mutations. In keeping with this finding, we saw upregulation of de novo transcription (Fig. 4f) , as well as increased steady-state amounts of mitochondrial proteins regulating transcription initiation (POLRMT and TFAM) and transcript stability (LRPPRC). A similar compensatory activation of mitochondrial transcription is well documented in mouse knockout models with defective mitochondrial translation caused by inactivation of nuclear genes regulating mitochondrial ribosomal biogenesis 18, 19 . The compensatory mechanism was not accompanied by an increase in the levels of tRNA Cys (Fig. 4d) , presumably because the m.5245T>C mutation reduces tRNA stability. However, the decrease in the levels of tRNA Cys was not on its own sufficient to cause an impairment of mitochondrial function. Increased RNA levels likely explain why mitochondrial respiration and isolated respiratory chain complex assembly and activities showed no obvious defects ( Supplementary  Fig. 3 ) and why we did not observe an increase in de novo translation ( Supplementary Fig. 4 ) in animals with high heteroplasmy for the m.3875delC mutation. Notably, a similar threshold toward a translational defect has previously been described in a person with a mutation in tRNA Lys (ref. 20) .
In conclusion, our observations show that intrafamilial differences in heteroplasmy are largely determined during prenatal oocyte development. In contrast to nonsynonymous protein-coding mutations in mtDNA, deleterious tRNA mutations are not subject to purifying selection during this process, resulting in oocyte heteroplasmy levels that are determined by random genetic drift. This has been observed in human oocytes harboring the most common pathogenic heteroplasmic mtDNA mutation, m.3243A>G (ref. 21) , which causes mitochondrial encephalomyopathy with stroke-like episodes. Despite being predicted to be deleterious, the m.5245T>C tRNA Cys and the m.3875delC tRNA Met mutations did not cause a biochemical defect in mice when respiratory chain function was assessed in tissue homogenates or in single muscle fibers, but there was an increase of overall mitochondrial RNA expression, which was most likely a compensatory response. This points toward a selective mechanism, which reduces the m.3875delC mutational burden by acting at the cell or organelle level in the developing embryo. Our findings corroborate observations in a comparable study in humans transmitting the m.3243A>G mutation 21 , which also showed no evidence of selection against a pathogenic variant during oocyte development.
The compensatory mechanism that we propose may prevent the appearance of an aberrant phenotype in the neonatal period. In keeping with this idea, we saw no impact on fecundity, although we cannot exclude the possibility that very high proportions of mtDNA carrying the m.3875delC mutation might lead to prenatal or neonatal fatality. If correct, this hypothesis might also explain why many human mtDNA disorders caused by tRNA mutations do not cause symptoms at or around birth but present clinically due to the progressive accumulation of mutation in non-dividing postmitotic tissues, causing neurological, ophthalmological, endocrine and cardiac diseases.
MeTHoDs
Methods and any associated references are available in the online version of the paper. oNLINe MeTHoDs Mouse breeding. The mouse line with the m.3875delC mutation was derived by backcrossing a homozygous Polg-mutant female to a C57BL/6N male 10 , followed by continuous backcrossing of the female germline, selecting for the wild-type Polg allele 11 .
Sequencing and mutation level quantification. Total mtDNA sequencing was performed as previously described 11 . The m.5245T>C and m.3875delC mutations lead to the loss of HphI and NlaIV restriction endonuclease restriction sites, respectively. The percentage of mitochondrial genomes with a given mutation was determined by last-cycle fluorescent RFLP analysis. For all mother and offspring calculations, ear-clip or tail-snip samples were obtained at weaning. Tissue samples were taken at various ages. Tissue, earclip and tail-snip DNA was isolated either by standard Proteinase K, phenol/ chloroform extraction followed by salt precipitation or by boiling the samples for 60 min in 75 µl of 25 mM NaOH and 0.2 mM EDTA and neutralizing with an equal volume of 40 mM Tris, pH 7.4. Individual PGCs and primary oocytes were lysed for 16 h at 55 °C in 20 µl of 50 mM Tris, pH 8.5, 0.5% Tween-20 and 100 µg/ml Proteinase K and were then incubated for 10 min at 85 °C to inactivate Proteinase K. For all reactions, 1 µl of lysate was used for PCR. Appropriate primers (Supplementary Table 5 ) were designed to contain 5′-terminal M13 tag sequences and the relevant restriction sites as an internal digestion control. The final cycle of a standard PCR with 30-35 cycles was spiked with 5 µM M13F-hex primer. PCR products were purified using Agencourt Ampure (Beckman Coulter) and eluted in 30 µl of dH 2 O. A 10-µl aliquot was digested overnight with 1 U of the appropriate restriction enzyme (New England Biolabs). We separated 1 µl of the digests in the presence of a GS500 size standard by fragment analysis on a 3730 DNA Analyzer and analyzed using the GeneMapper v. 4.0 software (all from Applied Biosystems). Peak heights were to determine the percentage of mtDNA with the mutation. Average values from at least three independent experiments were used for the quantification of mtDNA mutation levels in PGCs and offspring. Oocytes were quantified from a single experiment.
Isolation of PGCs and primary oocytes. PGCs (gametogonia) were isolated by mating female mice carrying the m.3875delC and m.5245T>C mutations with Stella-GFP BAC-homozygous C57BL/6N males 16 . Stella-GFP heterozygous embryos were collected at 13.5 d.p.c. in DMEM (Invitrogen) supplemented with 7.5% FCS and 10 mM HEPES. The gonadal ridges of each embryo were dissected using tungsten needles, pooled and washed in PBS, and 0.25% trypsin was added. After a 15-min incubation at 37 °C, trypsin was inactivated with FCS, and PGCs were released by physical disruption of the gonadal ridges. Single-PGC sorting was performed as previously described 4 , using a BD FACSAria II or III sorter (Becton Dickinson). PGCs were unidirectionally sorted into single wells of a 96-well plate. GFP was detected using a 100-mW sapphire laser, and GFP-positive PGCs were sorted at 20 p.s.i. using a 100-mm nozzle at a sort rate of 2,000 events per second. Instrument sensitivity was determined to be stable between sorts by internal quality control procedures. Plates were stored at -80 °C until required. PGCs were lysed, and the proportion of mutant mtDNA was quantified in triplicate. Primary oocytes were isolated from 3.5-d-old neonates (with the morning of birth calculated as day 0.5). The ovaries of the neonates were placed in a drop of warm PBS covered by mineral oil (Sigma) and were disrupted using fine watchmaker forceps. Primary oocytes were collected by mouth pipetting and transferred through drops of 0.2% hyaluronidase and/or PBS to remove any cumulus cells. Individual primary oocytes were placed into the 0.2-ml individual compartments of capped PCR strips (Eppendorf) by mouth pipetting and were lysed in a similar manner to the PGCs.
RNA extraction and RNA blot analysis. Total RNA was extracted using the ToTALLY RNA extraction kit (Ambion) following the manufacturer's instructions and was quantified using a Qubit fluorometer (Invitrogen). Steady-state levels of mitochondrial transcripts were determined by RNA blot analysis, using 750 ng of total RNA, essentially as previously described 22 . Mitochondrial tRNAs were separated on 10% polyacrylamide, 0.5× TBE gels, followed by electrical transfer onto nylon membranes (GE Healthcare). For conformational analysis and determination of the aminoacylation status of tRNAs, total RNA
